These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Use of mepolizumab in hypereosinophilic syndromes: The position and proposals of the national reference center for hypereosinophilic syndromes]. Kahn JE; Lefèvre G; Groh M Rev Med Interne; 2023 Apr; 44(4):155-157. PubMed ID: 36997273 [No Abstract] [Full Text] [Related]
3. Mepolizumab-a novel option for the treatment of hypereosinophilic syndrome in childhood. Schwarz C; Müller T; Lau S; Parasher K; Staab D; Wahn U Pediatr Allergy Immunol; 2018 Feb; 29(1):28-33. PubMed ID: 28986919 [TBL] [Abstract][Full Text] [Related]
4. New Treatment for Hypereosinophilic Syndrome. Aschenbrenner DS Am J Nurs; 2021 Mar; 121(3):23. PubMed ID: 33625006 [TBL] [Abstract][Full Text] [Related]
5. The Effect of Mepolizumab on the Lungs in a Boy with Hypereosinophilic Syndrome. Armoni Domany K; Shiran SI; Adir D; Lavie M; Levin D; Diamant N; Gut G; Benor S Am J Respir Crit Care Med; 2020 Jul; 202(2):e34-e35. PubMed ID: 32150442 [No Abstract] [Full Text] [Related]
6. Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes. Roufosse FE; Kahn JE; Gleich GJ; Schwartz LB; Singh AD; Rosenwasser LJ; Denburg JA; Ring J; Rothenberg ME; Sheikh J; Haig AE; Mallett SA; Templeton DN; Ortega HG; Klion AD J Allergy Clin Immunol; 2013 Feb; 131(2):461-7.e1-5. PubMed ID: 23040887 [TBL] [Abstract][Full Text] [Related]
7. Treatment of a 4-year-old boy with mepolizumab for lymphocytic hypereosinophilic syndrome. Cascio JA; Walsh M; Hoenig K; Davis B Ann Allergy Asthma Immunol; 2022 Aug; 129(2):254-255. PubMed ID: 35537650 [No Abstract] [Full Text] [Related]
8. Hypereosinophilic syndrome presenting as an unusual triad of eosinophilia, severe thrombocytopenia, and diffuse arterial thromboses, with good response to mepolizumab. Leon-Ferre RA; Weiler CR; Halfdanarson TR Clin Adv Hematol Oncol; 2013 May; 11(5):317-9. PubMed ID: 23880717 [No Abstract] [Full Text] [Related]
9. Familial clustering of hypereosinophilic diseases treated with mepolizumab: a case report from Japan. Kurosawa M; Sutoh Y; Sutoh E Eur Ann Allergy Clin Immunol; 2020 Jan; 52(1):39-44. PubMed ID: 31594295 [TBL] [Abstract][Full Text] [Related]